{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T19:19:16Z","timestamp":1768677556611,"version":"3.49.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005317","name":"Kermanshah University of Medical Sciences","doi-asserted-by":"publisher","award":["97134"],"award-info":[{"award-number":["97134"]}],"id":[{"id":"10.13039\/501100005317","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.leukres.2021.106691","type":"journal-article","created":{"date-parts":[[2021,8,21]],"date-time":"2021-08-21T10:29:08Z","timestamp":1629541748000},"page":"106691","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Aberrant expression profile of miR-32, miR-98 and miR-374 in chronic lymphocytic leukemia"],"prefix":"10.1016","volume":"111","author":[{"given":"Zohreh","family":"Rahimi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Ghorbani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajar","family":"Motamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0361-0096","authenticated-orcid":false,"given":"Nazanin","family":"Jalilian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.leukres.2021.106691_bib0005","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1172\/JCI23409","article-title":"In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells","volume":"115","author":"Messmer","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.leukres.2021.106691_bib0010","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood.V94.6.1840","article-title":"Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia","volume":"94","author":"Damle","year":"1999","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.leukres.2021.106691_bib0015","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nrc2764","article-title":"From pathogenesis to treatment of chronic lymphocytic leukaemia","volume":"10","author":"Zenz","year":"2010","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.leukres.2021.106691_bib0020","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1053\/j.seminoncol.2006.01.010","article-title":"Genomics of chronic lymphocytic leukemia microRNAs as new players with clinical significance","volume":"33","author":"Calin","year":"2006","journal-title":"Semin. Oncol."},{"issue":"9","key":"10.1016\/j.leukres.2021.106691_bib0025","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/nsmb0906-754","article-title":"L(ou)sy miRNA targets?","volume":"13","author":"Rajewsky","year":"2006","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"7","key":"10.1016\/j.leukres.2021.106691_bib0030","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2174\/138920210793175895","article-title":"MicroRNA: biogenesis, function and role in Cancer","volume":"11","author":"Macfarlane","year":"2010","journal-title":"Curr. Genomics"},{"issue":"1","key":"10.1016\/j.leukres.2021.106691_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/2211536611201010001","article-title":"MicroRNA: a small molecule with a big biological impact","volume":"1","author":"Zhou","year":"2012","journal-title":"Microrna"},{"issue":"19","key":"10.1016\/j.leukres.2021.106691_bib0040","doi-asserted-by":"crossref","first-page":"6230","DOI":"10.1158\/0008-5472.CAN-11-1717","article-title":"MicroRNA-32 upregulation by 1,25-dihydroxyvitamin D3 in human myeloid leukemia cells leads to Bim targeting and inhibition of AraC-induced apoptosis","volume":"71","author":"Gocek","year":"2011","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.leukres.2021.106691_bib0045","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.bbrc.2018.09.161","article-title":"MiR-374b-5p-FOXP1 feedback loop regulates cell migration, epithelial-mesenchymal transition and chemosensitivity in ovarian cancer","volume":"505","author":"Li","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.leukres.2021.106691_bib0050","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20181436","article-title":"MiR-454-3p and miR-374b-5p suppress migration and invasion of bladder cancer cells through targetting ZEB2","volume":"38","author":"Wang","year":"2018","journal-title":"Biosci. Rep."},{"issue":"1","key":"10.1016\/j.leukres.2021.106691_bib0055","first-page":"87","article-title":"MiR-32-5p regulates the proliferation and metastasis of cervical cancer cells by targeting HOXB8","volume":"23","author":"Liu","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.leukres.2021.106691_bib0060","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3892\/ol.2013.1667","article-title":"microRNA-32 inhibits the proliferation and invasion of the SGC-7901 gastric cancer cell line in vitro","volume":"7","author":"Zhang","year":"2014","journal-title":"Oncol. Lett."},{"issue":"11","key":"10.1016\/j.leukres.2021.106691_bib0065","doi-asserted-by":"crossref","first-page":"18629","DOI":"10.1002\/jcb.28874","article-title":"MicroRNA 32 promotes cell proliferation, migration, and suppresses apoptosis in colon cancer cells by targeting OTU domain containing 3","volume":"120","author":"Jin","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.leukres.2021.106691_bib0070","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12935-017-0383-0","article-title":"MicroRNA-32 promotes cell proliferation, migration and suppresses apoptosis in breast cancer cells by targeting FBXW7","volume":"17","author":"Xia","year":"2017","journal-title":"Cancer Cell Int."},{"issue":"1","key":"10.1016\/j.leukres.2021.106691_bib0075","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ygyno.2019.08.012","article-title":"Enumeration of deregulated miRNAs in liquid and tissue biopsies of cervical cancer","volume":"155","author":"Shukla","year":"2019","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.leukres.2021.106691_bib0080","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.bbrc.2015.10.044","article-title":"MiR-32 promotes gastric carcinoma tumorigenesis by targeting Kruppel-like factor 4","volume":"467","author":"Yan","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.leukres.2021.106691_bib0085","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18061281","article-title":"A panel of MicroRNAs as diagnostic biomarkers for the identification of prostate Cancer","volume":"18","author":"Daniel","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.leukres.2021.106691_bib0090","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1073\/pnas.0307323101","article-title":"Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers","volume":"101","author":"Calin","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.leukres.2021.106691_bib0095","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12964-018-0270-x","article-title":"KLF4, a miR-32-5p targeted gene, promotes cisplatin-induced apoptosis by upregulating BIK expression in prostate cancer","volume":"16","author":"Zhang","year":"2018","journal-title":"Cell Commun. Signal"},{"issue":"6","key":"10.1016\/j.leukres.2021.106691_bib0100","doi-asserted-by":"crossref","first-page":"4747","DOI":"10.1007\/s13277-015-3124-9","article-title":"MiR-32 induces cell proliferation, migration, and invasion in hepatocellular carcinoma by targeting PTEN","volume":"36","author":"Yan","year":"2015","journal-title":"Tumour Biol."},{"issue":"6","key":"10.1016\/j.leukres.2021.106691_bib0105","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1177\/1533034617745761","article-title":"MiR-98 promotes apoptosis of glioma cells via suppressing IKBKE\/NF-kappaB pathway","volume":"16","author":"Wang","year":"2017","journal-title":"Technol. Cancer Res. Treat."},{"issue":"2","key":"10.1016\/j.leukres.2021.106691_bib0110","doi-asserted-by":"crossref","first-page":"e23044","DOI":"10.1002\/jcla.23044","article-title":"miR-98-5p promotes apoptosis and inhibits migration and cell growth in papillary thyroid carcinoma through Bax\/Caspase-3 by HMGA2","volume":"34","author":"Qiu","year":"2020","journal-title":"J. Clin. Lab. Anal."},{"issue":"2","key":"10.1016\/j.leukres.2021.106691_bib0115","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.neuron.2013.10.062","article-title":"Transcriptome-wide discovery of microRNA binding sites in human brain","volume":"81","author":"Boudreau","year":"2014","journal-title":"Neuron"},{"issue":"10","key":"10.1016\/j.leukres.2021.106691_bib0120","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/abbs\/gmw084","article-title":"MiR-98 promotes chondrocyte apoptosis by decreasing Bcl-2 expression in a rat model of osteoarthritis","volume":"48","author":"Wang","year":"2016","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"issue":"1","key":"10.1016\/j.leukres.2021.106691_bib0125","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3892\/mmr.2016.5268","article-title":"Placental microRNA expression in pregnancies complicated by superimposed preeclampsia on chronic hypertension","volume":"14","author":"Vashukova","year":"2016","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.leukres.2021.106691_bib0130","first-page":"91","article-title":"MicroRNA-98 reduces amyloid beta-protein production and improves oxidative stress and mitochondrial dysfunction through the Notch signaling pathway via HEY2 in Alzheimer\u2019s disease mice","volume":"43","author":"Chen","year":"2019","journal-title":"Int. J. Mol. Med."},{"issue":"5","key":"10.1016\/j.leukres.2021.106691_bib0135","first-page":"1491","article-title":"Downregulation of miR-374b-5p promotes chemotherapeutic resistance in pancreatic cancer by upregulating multiple anti-apoptotic proteins","volume":"52","author":"Sun","year":"2018","journal-title":"Int. J. Oncol."},{"issue":"1","key":"10.1016\/j.leukres.2021.106691_bib0140","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1182\/blood-2013-09-527234","article-title":"miR-150 influences B-cell receptor signaling in chronic lymphocytic leukemia by regulating expression of GAB1 and FOXP1","volume":"124","author":"Mraz","year":"2014","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.leukres.2021.106691_bib0145","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s00018-011-0816-1","article-title":"Antithetic roles of proteoglycans in cancer","volume":"69","author":"Garusi","year":"2012","journal-title":"Cell. Mol. Life Sci."},{"issue":"4","key":"10.1016\/j.leukres.2021.106691_bib0150","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1182\/blood-2004-04-1233","article-title":"Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes","volume":"105","author":"Mayr","year":"2005","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.leukres.2021.106691_bib0155","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1365-2141.2010.08362.x","article-title":"Silencing of ROR1 and FMOD with siRNA results in apoptosis of CLL cells","volume":"151","author":"Choudhury","year":"2010","journal-title":"Br. J. Haematol."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212621001922?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212621001922?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T01:02:15Z","timestamp":1758934935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212621001922"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":31,"alternative-id":["S0145212621001922"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2021.106691","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aberrant expression profile of miR-32, miR-98 and miR-374 in chronic lymphocytic leukemia","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2021.106691","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106691"}}